Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins

BACKGROUND: Despite being a mainstay for treating superficial bladder carcinoma and a promising agent for interstitial cystitis, the precise mechanism of Bacillus Calmette-Guerin (BCG) remains poorly understood. It is particularly unclear whether BCG is capable of altering gene expression beyond its...

Descripción completa

Detalles Bibliográficos
Autores principales: Saban, Marcia R, Hellmich, Helen L, Simpson, Cindy, Davis, Carole A, Lang, Mark L, Ihnat, Michael A, O'Donnell, Michael A, Wu, Xue-Ru, Saban, Ricardo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212656/
https://www.ncbi.nlm.nih.gov/pubmed/17980030
http://dx.doi.org/10.1186/1471-2407-7-204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212656/
https://www.ncbi.nlm.nih.gov/pubmed/17980030
http://dx.doi.org/10.1186/1471-2407-7-204

Ejemplares similares